← Torna allo Screener

Omnicell

OMCL Small Cap

Healthcare · Health Information Services

Aggiornato: May 2, 2026, 22:05 UTC

36,51 €
+3.33% oggi
52W: 19,33 € – 46,92 €
52W Low: 19,33 € Posizione: 62.3% 52W High: 46,92 €

Metriche Chiave

P/E Ratio
97.27x
Rapporto P/E
Forward P/E
19.5x
P/E Forward
P/S Ratio
1.59x
Prezzo/Vendite
EV/EBITDA
26.05x
Valore Impresa/EBITDA
Rendimento Dividendi
Rendimento annuale da dividendi
Cap. di Mercato
1,7 Mrd. €
Capitalizzazione di Mercato
Crescita Ricavi
14.9%
Crescita Ricavi Anno su Anno
Margine di Profitto
1.67%
Margine Netto
ROE
1.63%
Return on Equity
Beta
0.86
Sensibilità al mercato
Interesse Corto
6.73%
% del flottante in vendita allo scoperto
Volume Medio
707,177
Volume Medio Giornaliero

Analisi della Valutazione

Segnale
Sopravvalutata
vs. P/E medio S&P 500 (24,7x)
Consenso degli Analisti
Acquisto Forte
7 analisti
Prezzo Obiettivo Medio
52,28 €
+43.19% potenziale
Range Obiettivo
46,92 € – 59,71 €

Informazioni sull'Azienda

Settore: Healthcare Industria: Health Information Services Paese: United States Dipendenti: 3,580 Borsa: NMS

Omnicell Stock at a Glance

Omnicell (OMCL) is currently trading at 36,51 € with a market capitalization of 1,7 Mrd. €. The trailing P/E ratio stands at 97.27x, with a forward P/E of 19.5x. The 52-week range spans from 19,33 € to 46,92 €; the current price is 22.2% below the yearly high. Year-over-year revenue growth stands at +14.9%. The net profit margin stands at 1.67%.

💰 Dividendo

Omnicell currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Raccomandazioni degli Analisti

7 analysts rate Omnicell (OMCL) on consensus: Acquisto Forte. The average price target is 52,28 €, implying +43.19% from the current price. Analyst price targets range from 46,92 € to 59,71 €.

Tesi di Investimento: Punti di Forza e Debolezze

Punti di Forza
  • Analyst consensus: Strong Buy
  • Solid balance sheet with low debt (D/E 15.16)
  • Positive free cash flow
Debolezze
  • Low profitability (1.67% margin)
  • High valuation multiple (P/E 97.27x)
  • Currently flagged as overvalued

Panoramica Tecnica

MM 50 Giorni
31,85 €
+14.62% vs. prezzo
MM 200 Giorni
31,42 €
+16.21% vs. prezzo
Sotto Massimo 52S
−22.2%
46,92 €
Sopra Minimo 52S
+88.9%
19,33 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profilo di Rischio

Rischio di Mercato (Beta)
0.86 · Market-like
Moves less than the overall market
Short Interest
6.73% · Elevated
% del flottante in vendita allo scoperto
Debt-to-Equity
15.16 · Low
Debito totale / patrimonio

The data points to relatively defensive market behavior, elevated short interest (6.73%).

Dati di Trading

50-Day MA: 31,85 €
200-Day MA: 31,42 €
Volume: 616,909
Volume Medio: 707,177
Ratio Corto: 5.4
Rapporto P/B: 1.56x
Debito/Patrimonio: 15.16x
Flusso di Cassa Libero: 106 M €

Where can I buy Omnicell?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Scroll to Top